These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 10678602)

  • 41. Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients.
    Hesse S; Lücke D; Malezic M; Bertelt C; Friedrich H; Gregoric M; Mauritz KH
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57(11):1321-4. PubMed ID: 7964805
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Management of spasticity in adults: practical application of botulinum toxin.
    Pathak MS; Nguyen HT; Graham HK; Moore AP
    Eur J Neurol; 2006 Feb; 13 Suppl 1():42-50. PubMed ID: 16417597
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Efficacy of Ultrasound-guided Selective Botulinum Toxin Type A Therapy for Finger Spasticity Following Stroke: A Case Report.
    Furukawa T; Kurihara Y; Masakado Y
    Tokai J Exp Clin Med; 2019 Apr; 44(1):20-24. PubMed ID: 30963525
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Botulinum toxin treatment of adult spasticity : a benefit-risk assessment.
    Sheean G
    Drug Saf; 2006; 29(1):31-48. PubMed ID: 16454533
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Can botulinum toxin decrease carer burden in long term care residents with upper limb spasticity? A randomized controlled study.
    Lam K; Lau KK; So KK; Tam CK; Wu YM; Cheung G; Liang KS; Yeung KM; Lam KY; Yui S; Leung C
    J Am Med Dir Assoc; 2012 Jun; 13(5):477-84. PubMed ID: 22521630
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of spasticity on cortical somatosensory-evoked potentials: changes of cortical somatosensory-evoked potentials after botulinum toxin type A injection.
    Park ES; Park CI; Kim DY; Kim YR
    Arch Phys Med Rehabil; 2002 Nov; 83(11):1592-6. PubMed ID: 12422331
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel approach to the application of botulinum toxin to the flexor digitorum superficialis muscle in acquired brain injury.
    Munin MC; Navalgund BK; Levitt DA; Breisinger TP; Zafonte RD
    Brain Inj; 2004 Apr; 18(4):403-7. PubMed ID: 14742153
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial: effect on impairment, activity limitation, and pain.
    Shaw LC; Price CI; van Wijck FM; Shackley P; Steen N; Barnes MP; Ford GA; Graham LA; Rodgers H;
    Stroke; 2011 May; 42(5):1371-9. PubMed ID: 21415398
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comprehensive Assessment of the Time Course of Biomechanical, Electrophysiological and Neuro-Motor Effects after Botulinum Toxin Injections in Elbow Flexors of Chronic Stroke Survivors with Spastic Hemiplegia: A Cross Sectional Observation Study.
    Chen YT; Liu Y; Zhang C; Magat E; Zhou P; Zhang Y; Li S
    Toxins (Basel); 2022 Jan; 14(2):. PubMed ID: 35202132
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke.
    Childers MK; Brashear A; Jozefczyk P; Reding M; Alexander D; Good D; Walcott JM; Jenkins SW; Turkel C; Molloy PT
    Arch Phys Med Rehabil; 2004 Jul; 85(7):1063-9. PubMed ID: 15241751
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and safety of NABOTA in post-stroke upper limb spasticity: a phase 3 multicenter, double-blinded, randomized controlled trial.
    Nam HS; Park YG; Paik NJ; Oh BM; Chun MH; Yang HE; Kim DH; Yi Y; Seo HG; Kim KD; Chang MC; Ryu JH; Lee SU
    J Neurol Sci; 2015 Oct; 357(1-2):192-7. PubMed ID: 26233808
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Botulinum Toxin (BT) injection improves voluntary motor control in selected patients with post-stroke spasticity.
    Chang SH; Francisco GE; Li S
    Neural Regen Res; 2012 Jun; 7(18):1436-1439. PubMed ID: 24966872
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Botulinum toxin to treat upper-limb spasticity in hemiparetic patients: analysis of function and kinematics of reaching movements.
    Bensmail D; Robertson JV; Fermanian C; Roby-Brami A
    Neurorehabil Neural Repair; 2010; 24(3):273-81. PubMed ID: 20067949
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence to practice: botulinum toxin in the treatment of spasticity post stroke.
    Teasell R; Foley N; Pereira S; Sequeira K; Miller T
    Top Stroke Rehabil; 2012; 19(2):115-21. PubMed ID: 22436359
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
    Elovic EP; Brashear A; Kaelin D; Liu J; Millis SR; Barron R; Turkel C
    Arch Phys Med Rehabil; 2008 May; 89(5):799-806. PubMed ID: 18452724
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The management of hyperfunctional facial lines with botulinum toxin. A collaborative study of 210 injection sites in 162 patients.
    Blitzer A; Binder WJ; Aviv JE; Keen MS; Brin MF
    Arch Otolaryngol Head Neck Surg; 1997 Apr; 123(4):389-92. PubMed ID: 9109785
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Can the positions of the spastic upper limb in stroke survivors help muscle choice for botulinum toxin injections?
    Gomes ALS; Mello FF; Cocicov Neto J; Benedeti MC; Modolo LFM; Riberto M
    Arq Neuropsiquiatr; 2019 Sep; 77(8):568-573. PubMed ID: 31508683
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The importance of electromyographic guidance and electrical stimulation for injection of botulinum toxin.
    Childers MK
    Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):781-92. PubMed ID: 14580037
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Physical and occupational therapy considerations in adult patients receiving botulinum toxin injections for spasticity.
    Albany K
    Muscle Nerve Suppl; 1997; 6():S221-31. PubMed ID: 9826993
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and safety of treatment with incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity.
    Kaňovský P; Slawek J; Denes Z; Platz T; Comes G; Grafe S; Pulte I
    J Rehabil Med; 2011 May; 43(6):486-92. PubMed ID: 21533328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.